Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2021 Filed Feb 3, 2021 23:51 UTC |
Pusey Leigh AnnSVP, Corp. Affairs & Comm.
|
Exercise / conversionCommon Stock | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000028 · wf-form4_161239627141009.xml · nonDerivative · entry 1 Pusey Leigh Ann · CIK 0001708919 · SVP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:43 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,146 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000026 · wf-form4_161239577477766.xml · derivative · entry 5 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,146 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:43 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
Tax withholdingCommon Stock | 5,438 | $207.97 | $1,130,940.86 |
DisclosureSEC source: 0000059478-21-000026 · wf-form4_161239577477766.xml · nonDerivative · entry 2 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,481 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:43 UTC |
O'Neill MylesSVP & Pres., Mfg. Operations
|
Exercise / conversionCommon Stock | 12,146 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000026 · wf-form4_161239577477766.xml · nonDerivative · entry 1 O'Neill Myles · CIK 0001725140 · SVP & Pres., Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:57 UTC |
Ricks David ADirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 75,387 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000030 · wf-form4_161239665929320.xml · derivative · entry 4 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,387 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:57 UTC |
Ricks David ADirector · President & CEO
|
Tax withholdingCommon Stock | 33,738 | $207.97 | $7,016,491.86 |
DisclosureSEC source: 0000059478-21-000030 · wf-form4_161239665929320.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,901 Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:57 UTC |
Ricks David ADirector · President & CEO
|
Exercise / conversionCommon Stock | 75,387 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000030 · wf-form4_161239665929320.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:02 UTC |
Shah Aarti S.SVP & CIDO
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000032 · wf-form4_161239691232704.xml · derivative · entry 4 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,282 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:02 UTC |
Shah Aarti S.SVP & CIDO
|
Tax withholdingCommon Stock | 2,780 | $207.97 | $578,156.60 |
DisclosureSEC source: 0000059478-21-000032 · wf-form4_161239691232704.xml · nonDerivative · entry 2 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,589 Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:02 UTC |
Shah Aarti S.SVP & CIDO
|
Exercise / conversionCommon Stock | 6,282 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000032 · wf-form4_161239691232704.xml · nonDerivative · entry 1 Shah Aarti S. · CIK 0001725292 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:26 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,754 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000036 · wf-form4_161239834705746.xml · derivative · entry 4 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,754 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:26 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
Tax withholdingCommon Stock | 7,490 | $207.97 | $1,557,695.30 |
DisclosureSEC source: 0000059478-21-000036 · wf-form4_161239834705746.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,910 Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:26 UTC |
Zulueta Alfonso GSVP & President, Lilly Int'l
|
Exercise / conversionCommon Stock | 16,754 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000036 · wf-form4_161239834705746.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP & President, Lilly Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 01:22 UTC |
Smiley Joshua LSVP and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 19,266 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000038 · wf-form4_161240176096650.xml · derivative · entry 4 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,266 shares Expires 2021-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 01:22 UTC |
Smiley Joshua LSVP and CFO
|
Tax withholdingCommon Stock | 8,452 | $207.97 | $1,757,762.44 |
DisclosureSEC source: 0000059478-21-000038 · wf-form4_161240176096650.xml · nonDerivative · entry 2 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,250 Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 01:22 UTC |
Smiley Joshua LSVP and CFO
|
Exercise / conversionCommon Stock | 19,266 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000038 · wf-form4_161240176096650.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 02:43 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 10 | $198.48 | $1,984.80 |
DisclosureSEC source: 0000059478-21-000006 · wf-form4_161128341846245.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,732 Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 02:49 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 55 | $198.48 | $10,916.40 |
DisclosureSEC source: 0000059478-21-000008 · wf-form4_161128377092505.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,144 Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:04 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 148,766 | $191.14 | $28,435,579.54 |
DisclosureSEC source: 0001209191-21-003958 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,487,343 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.83 to $191.6538 , inclusive. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:04 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,298 | $190.49 | $7,866,897.32 |
DisclosureSEC source: 0001209191-21-003958 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,636,109 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.83 to $190.829, inclusive. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 18:04 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 24,936 | $189.30 | $4,720,384.80 |
DisclosureSEC source: 0001209191-21-003958 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,677,407 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.80 to $189.7949, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 16:23 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,722 | $187.12 | $1,819,190.36 |
DisclosureSEC source: 0001209191-21-003538 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,702,343 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.00 to $187.58, inclusive. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 16:23 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 95,353 | $186.47 | $17,780,569.26 |
DisclosureSEC source: 0001209191-21-003538 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,712,065 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.00 to $186.995, inclusive. Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 16:23 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 104,925 | $185.40 | $19,453,304.85 |
DisclosureSEC source: 0001209191-21-003538 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,807,418 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.00 to $185.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 300 | $187.46 | $56,237.10 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,912,343 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.45 to $187.46, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 48,871 | $187.00 | $9,138,681.52 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,912,643 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.44 to $187.43, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 42,301 | $185.63 | $7,852,250.03 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,961,514 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.44 to $186.435, inclusive. Read SEC document |
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 128,528 | $184.87 | $23,760,585.78 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,003,815 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.44 to $185.4375, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 19:50 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 12 | $168.78 | $2,025.36 |
DisclosureSEC source: 0000059478-20-000192 · wf-form4_160875302965624.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,722 Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 01:01 UTC |
Zakrowski Donald AChief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 4,810 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000183 · wf-form4_160695729588795.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,810 Underlying: Common Stock · 4,810 shares Expires 2023-12-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:19 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000159 · wf-form4_160575233895792.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,870 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:20 UTC |
Walker KarenDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000161 · wf-form4_160575242550974.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,209 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:22 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000163 · wf-form4_160575252506909.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,310 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:23 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 1,259 | $140.59 | $177,002.81 |
DisclosureSEC source: 0000059478-20-000165 · wf-form4_160575260133594.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,651 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:24 UTC |
Bertozzi Carolyn RDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000167 · wf-form4_160575263875107.xml · nonDerivative · entry 1 Bertozzi Carolyn R · CIK 0001698766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,243 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:25 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000170 · wf-form4_160575272999865.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,038 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:26 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000171 · wf-form4_160575275310847.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,707 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:27 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000174 · wf-form4_160575285762668.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,279 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:28 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000175 · wf-form4_160575286680448.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,818 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:29 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000177 · wf-form4_160575297494178.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,981 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:30 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000179 · wf-form4_160575301917734.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,566 Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 02:33 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 1,245 | $140.59 | $175,034.55 |
DisclosureSEC source: 0000059478-20-000181 · wf-form4_160575321158971.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,730 Read SEC document |
| October 19, 2020 Filed Oct 21, 2020 18:53 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 14 | $142.80 | $1,999.20 |
DisclosureSEC source: 0000059478-20-000149 · wf-form4_160330641344291.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,392 Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:19 UTC |
Smiley Joshua LSVP and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,947 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000143 · wf-form4_160191473067021.xml · derivative · entry 4 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,947 shares Expires 2020-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:19 UTC |
Smiley Joshua LSVP and CFO
|
Tax withholdingCommon Stock | 3,482 | $148.02 | $515,405.64 |
DisclosureSEC source: 0000059478-20-000143 · wf-form4_160191473067021.xml · nonDerivative · entry 2 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,436 Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:19 UTC |
Smiley Joshua LSVP and CFO
|
Exercise / conversionCommon Stock | 7,947 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000143 · wf-form4_160191473067021.xml · nonDerivative · entry 1 Smiley Joshua L · CIK 0001725189 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 21:06 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 13 | $151.18 | $1,965.34 |
DisclosureSEC source: 0000059478-20-000141 · wf-form4_160089516405487.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,378 Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 20:25 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
SaleCommon Stock | 5,000 | $151.01 | $755,050.00 |
DisclosureSEC source: 0000059478-20-000139 · wf-form4_159976950463304.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,580 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2020 and amended on September 8, 2020. Read SEC document |
| September 08, 2020 Filed Oct 28, 2020 19:24 UTC Amendment |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
SaleCommon Stock | 5,000 | $151.01 | $755,050.00 |
DisclosureSEC source: 0000059478-20-000157 · wf-form4a_160391304057001.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,580 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 21:04 UTC |
Mason Michael BSr. VP & Pres., Lilly Diabetes
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-20-000137 · wf-form4_159908062423990.xml · derivative · entry 4 Mason Michael B · CIK 0001799419 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,244 shares Expires 2020-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.